Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Abstract
Sclerostin is an osteocyte-derived inhibitor of osteoblast activity. The monoclonal antibody romosozumab binds to sclerostin and increases bone...
Paper Details
Title
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Published Date
Jan 30, 2014
Volume
370
Issue
5
Pages
412 - 420
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History